Summary
66 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 17% a year over the last 3 years.
- Out of every 100 GBP of revenue, 60 GBP is left as net profit.
- It has raised its dividend 5 years in a row and pays out only 37% of profit.
What to watch
- The share price is above the Bulios Fair Price.
- It passes only 3 of the 9 points of the Piotroski financial health test.
- Analysts expect revenue to fall by 8.4% this fiscal year.
- Revenue growth is slowing: 3.5% a year over the last 3 years against 9.2% over 5 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensivePrice against the Bulios Fair Price
P/E against the industry (REIT - Industrial)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 12.6 GBP for 1 GBP of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (GBP)
Diluted EPS (GBP)
- Analyst estimate
Revenue grew by 9.2% a year over 5 years. Over the last 3 years it grew by 3.5% a year. For the next fiscal year analysts expect revenue to fall by 8.4%. Earnings per share grew by 17% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 2.94%
- Paid out of profit
- 37%
- Raised in a row
- 5 years
You receive $0.31 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 5
- Hold 2
- Sell 0
No analyst has published a price target.
71% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.